There are limited experimental data pointing out Mg ability to reduce organ Cd accumulation and its benefi cial effects against Cd-altered bioelement levels and parameters of oxidative stress (10) (11) (12) . The wide safety margin between beneficial and toxic concentrations of Mg in tissues and biological fl uids suggests that Mg may be used to prevent and treat Cd poisoning. This potential is of great importance, having in mind that the therapy of Cd poisoning has not yet been established. However, the exact mechanisms of Mg beneficial effects against Cd poisoning are not completely understood.
The aim of this study was to determine how Mg affects parameters of oxidative stress in the blood of rats acutely poisoned with Cd. For this purpose we measured plasma enzyme superoxide dismutase (SOD) activity, superoxide anion (O 2 .-) content, total oxidative status (TOS), malondialdehyde (MDA), and advanced oxidation protein products (AOPP) levels. Two routes of Cd exposure were chosen on the basis of two possible scenarios of human exposure to Cd: oral (or) as a model for exposure via food and water, and intraperitoneal (ip) as a model for parenteral exposure, i.e. inhalation. Our previous study (13) has shown that oral pretreatment with Mg had benefi cial effects on all parameters of oxidative stress in the liver, suggesting gastrointestinal tract (GIT) as an important site of Cd and Mg interactions. However, the benefi cial effect of Mg ip treatment observed in that study showed that competition between Cd and Mg in GIT can not be the only explanation for the protective effects of Mg against Cd poisoning. In this study we investigated the effects of oral and intraperitoneal Mg on parameters of oxidative stress rat plasma 24 h after Cd treatment in order to better understand possible protective mechanisms of Mg pretreatment against Cd toxicity.
MATERIALS AND METHODS
The study protocol was approved by the Ethics Committee of the Military Medical Academy for animal experiments. Procedures involving animals and their care were in compliance with Guidelines for Animal Studies no. 282-12/2002.
Animals
The study included 40 male Wistar rats weighing 170 g to 240 g, which were obtained from the Military Medical Academy, Belgrade. The animals were housed in cages under standard laboratory conditions [temperature (22±2) ºC; relative humidity (50±10) %] with light and dark cycles exchanging every 12 h. They had free access to water and received standard pelleted diet mixture (Veterinary Institute "Subotica", Subotica, Serbia). The diet contained 2.4 mg g -1 Mg and 19.2 ng g -1 Cd (as determined in our laboratory).
Experimental design
The animals were randomised into fi ve groups of eight rats: control group, Cd or , Cd+Mg or , Cd ip , and Cd+Mg ip group. Oral and intraperitoneal doses of Cd producing toxic effects and Mg doses with possible protective effects were chosen on the basis of our previous experiments and literature data (10) (11) (12) (13) (14) (15) The animals were killed under ether anaesthesia twentyfour hours after Cd poisoning and blood samples taken from the heart and collected into heparin tubes. One portion of collected blood was used for cadmium, magnesium, and zinc determination, while the other portion was centrifuged at 837xg for 15 min and various parameters of oxidative stress were determined in the obtained plasma.
Analytical procedures
All chemicals and reagents were purchased from Merck (Darmstadt, Germany) and Sigma-Aldrich (St. Luis, USA). Parameters of oxidative stress in blood plasma SOD activity, O 2 .-, MDA, AOPP, and TOS were measured using an ILAB 300+ analyser (Instrumentation Laboratory, Lexington, Massachusetts).
Plasma SOD (16) was assayed according to the Misra and Fridovich method (17) in which inhibition of epinephrine auto-oxidation by SOD in the examined sample is recorded as an increase in absorbance at 505 nm for 3 min. One unit of SOD activity is defi ned as the activity that inhibits auto-oxidation of adrenalin by 50 %. The rate of nitroblue tetrazolium reduction (NBT) was monitored at 515 nm every 15 s within a minute to measure the level of O 2 .
- (18) . Lipid peroxidation (LPO) was evaluated by measuring MDA concentration according to a method described by Girroti et al. (19) . This assay is based on the formation of a complex between thiobarbituric acid and MDA, which absorbs at 535 nm. AOPP levels, which indicate the level of ROS-mediated protein damage, were determined by the spectroscopic analysis of modifi ed proteins at 340 nm (20) and expressed as chloramine-T equivalents (μmol L -1 ). Total oxidative status was determined using the method described by Erel (21) . The assay is based on the oxidation of ferrous ion to ferric ion in the presence of various oxidant species in acidic medium and the measurement of the formed ferric ion by xylenol orange.
For Cd, Mg, and Zn determination blood samples were mineralised with a mixture of HNO 3 and HClO 4 in a ratio 4:1, and Cd concentrations were measured by graphite furnace atomic absorption spectrophotometry (AAS, SpectrAA 220, GTA 110, Varian, Melbourne, Australia), while Mg and Zn concentrations were determined by fl ame atomic absorption spectrophotometry (AAS, apparatus GBC 932AA, Victoria, Australia). The accuracy and precision of analysis were established by the analysis of these elements in standard reference bovine liver from the National Bureau of Standards (NIST SRM 1577a bovine liver, National Institute of Standards and Technology, Gaithersburg, Maryland, USA).
Statistical analysis
For statistical analysis we used SPSS (version 11.5 for Windows) and MedCalc ® 12.1.4. The one-sample Kolmogorov-Smirnov test showed that only Cd and Mg concentrations were normally distributed and for these parameters the results were presented as means±SD and statistical evaluation of the data was performed using a one-way analysis of variance (ANOVA). Other parameters were presented as medians and ranges and statistical evaluation was performed using Kruskal-Wallis nonparametric test followed by post-hoc Conover test for pairwise comparison. Furthermore, Spearman's correlation analysis was used to determine the relationship between SOD activity and Zn levels in blood. Statistical signifi cance was defi ned as P<0.05.
RESULTS

SOD activity
Cadmium given both orally or intraperitoneally decreased SOD activity signifi cantly compared to control values, while no signifi cant difference was observed in SOD activity between the Cd or and Cd ip groups. Oral Mg co-treatment managed to prevent any signifi cant changes in SOD activity since there were no signifi cant difference between the Cd+Mg or group and control group, whereas i.p. Mg treatment resulted in higher SOD activity compared with the Cd ip group although SOD activity was still signifi cantly lower than in the control group (Table 1) .
.
-and TOS levels
Regardless of the route of administration, Cd induced a signifi cant increase in both O 2 .-and TOS levels compared to controls, and this increase was much higher in the group that received Cd intraperitoneally for both parameters. Oral Mg managed to completely prevent changes in O 2 .-and TOS levels, keeping them within control range. Intraperitoneal Mg co-treatment induced a signifi cant decrease in O 2 .
-levels compared to the Cd ip group, but could not maintain O 2 .-levels within control range. On the other hand, intraperitoneal Mg managed to prevent the increase in TOS levels, as control and Cd+Mg ip . TOS levels did not differ signifi cantly (Table 1) .
MDA and AOPP levels
Both oral and intraperitoneal Cd treatment resulted in a signifi cant increase in MDA and AOPP levels compared to controls, and these levels were signifi cantly higher in the group treated intraperitoneally when compared to oral treatment. Oral administration of Mg in Cd-poisoned rats signifi cantly decreased the level of both parameters to values observed in control group. Intraperitoneal administration showed the same positive effect on AOPP levels as oral, while MDA levels in the Cd+Mg ip group were signifi cantly lower than in the Cd ip group, but higher than in controls (Table 1) . Table 2 shows that Cd blood levels in both intraperitoneally treated groups were signifi cantly higher than in the control and orally treated groups. Oral Cd treatment did signifi cantly affect blood Cd levels, and neither did Cd+Mg co-treatment. Blood Mg was in the control range in all groups. Table 2 also shows changes in blood Zn of control and treated rats. A signifi cant decrease was observed in both the Cd or and Cd ip groups compared to control, with no signifi cant difference between these two particular groups. However, oral Mg administration managed to prevent Cd-induced changes in Zn levels.
Cd, Mg, and Zn concentrations
DISCUSSION
All investigated parameters of oxidative stress in rat plasma were negatively affected by Cd treatment. These observed changes are in accordance with our previous results and results of other authors who have suggested that Cd toxicity is mediated by decrease in antioxidant enzymes, production of reactive oxygen species and lipid peroxidation (13, 14, 22, 23) . However, more pronounced negative effects of Cd, except for SOD activity, were observed in rats that were treated intraperitoneally. This can be explained by signifi cantly higher blood Cd levels in Cd ip than in Cd or group.
Our study shows that Cd infl uences plasma SOD activity in rats, but that this effect does not depend on the route of exposure. Similarly, no route-dependent changes in SOD activity were found in the liver of Cd-poisoned rats (13) . The antagonism between Cd and Zn has been investigated for many decades, and it is known that Cd can replace Zn in many vital enzymatic reactions (24) (25) (26) . This suggests that Cd may induce changes in SOD activity by interacting with Zn, which is present in the active centre of SOD isoenzymes beside Cu and Mg. Blood Zn levels in both the Cd or and Cd ip treated rats were signifi cantly lower than control, but no signifi cant difference was found between routes of exposure, which may explain similar levels of SOD activity in these groups. This suggests that mainly affects SOD through interaction with Zn. This fi nding is supported by Spearman's correlation analysis that revealed a positive correlation between blood Zn and SOD activity (ρ=0.339,
P=0.035).
This study was focused on how Mg affects blood parameters of oxidative stress in rats acutely poisoned with Cd. The results show that oral Mg pre-treatment was effective in reducing this stress: SOD activity, O 2 .-, TOS, MDA, and AOPP were all restored to control values. These results are in accordance with our previous investigations that demonstrated benefi cial effects of Mg on parameters of oxidative stress in the liver (13, 27) . This protective effect of oral Mg supplementation could be explained by Mg and Cd interactions in the gastrointestinal tract (GIT) where Mg competes with Cd for divalent metal transporters. Recent studies (28, 29) have shown that Mg absorption from the GIT happens through divalent cation channels TRPM 7 and TRPM 6 (transient receptor potential melastation-related 7 and 6), which have been demonstrated to be primarily Mg 2+ channels, but are also implicated in Cd trafficking. Besides, Mg transporter protein-MagT2 can also be engaged in other divalent cation transport. Recent data (29) also suggested that ancient conserved domain protein 2 is a non-selective divalent cation transporter which favours transfer of divalent cations transport in case of Mg defi ciency. Therefore, excessive Mg intake can signifi cantly decrease Cd transport through these channels. However, this principle alone can not explain our results, as there was no significant difference in blood Cd levels between the Cd or and Cd+Mg or groups. Concentration of Cd in these treated groups were even similar to those obtained in control group, but it should be pointed out that Cd was determined only 24 h after the treatment when both Cd and Mg were already distributed in the organism. The positive effects of Mg on SOD activity can be explained by the protective effect of Mg on Zn levels in blood since oral Mg administration counteracts Cd-induced Zn reduction in blood. One explanation for this phenomenon may be that Mg prevents Cdinduced extensive loss of Zn via urine, which was observed in our previous study on rabbits (30 .-as a substrate. Intraperitoneal Mg pretreatment totally reversed Cd-induced changes in AOPP levels and managed to counteract, at least partly, Cd-induced changes in MDA levels. Under the same experimental conditions, no effect on SOD activity was observed, perhaps as a consequence of unchanged blood Zn levels after intraperitoneal Mg supplementation.
Our fi ndings show that both oral and intraperitoneal Mg pretreatment have a protective effect against Cd poisoning, but also indicate that the route of Mg administration affects interactions between Cd and Mg, as oral administration provides more benefi cial effects. These differences can be explained by the fact that after oral treatment, Mg is present in the GIT where it can modify Cd absorption. Furthermore, oral Mg pretreatment in this study prevented blood Zn drop while intraperitoneal treatment did not.
CONCLUSION
The results of this study show that acute intraperitoneal administration of Cd has much more potent toxic effect than oral Cd administration on parameters of oxidative stress in rat plasma. Our results also show that oral and intraperitoneal Mg pretreatment can have a beneficial effect on Cdinduced oxidative stress in rat plasma, but this effect was more pronounced after oral administration. As no specifi c therapy has been adopted for Cd poisoning, the observed beneficial effects of both oral and intraperitoneal Mg encourage further use of Mg as protection against the toxic effects caused by Cd.
